{"gene":"TOX","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":2002,"finding":"TOX is an HMG-box DNA-binding protein whose expression is upregulated by both pre-TCR and TCR activation of immature thymocytes but not by TCR activation of mature naïve T cells; transgenic overexpression of TOX in mice expands CD8+ and reduces CD4+ single positive thymocyte subpopulations by perturbing lineage commitment through reduced sensitivity to TCR-mediated signaling.","method":"Gene chip isolation of Tox, transgenic mouse overexpression, thymocyte phenotyping","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — original discovery paper with transgenic mouse model and defined cellular phenotype, replicated by subsequent studies","pmids":["11850626"],"is_preprint":false},{"year":2004,"finding":"TOX expression in double-positive thymocytes is calcineurin-dependent; TOX is sufficient to induce CD8 gene demethylation, initiate positive selection to the CD8 lineage independently of MHC-TCR interactions, and upregulate Runx3, implicating CD4 silencing. A strong TCR signal can override this TOX-mediated cell fate.","method":"Calcineurin inhibitor treatment, TOX overexpression in thymocytes, CD8 gene methylation assay, Runx3 expression analysis, transgenic mouse studies","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including epigenetic (methylation) assay, genetic overexpression, and signaling pathway epistasis","pmids":["15078895"],"is_preprint":false},{"year":2008,"finding":"TOX is required for CD4 T cell lineage development; loss of TOX causes a severe block at the CD4loCD8lo transitional stage of positive selection, resulting in failure of CD4+ T cells, regulatory T cells, and NKT cells to develop, while functional CD8+ T cells are generated normally.","method":"TOX-deficient (knockout) mouse model, flow cytometric phenotyping of thymocyte subpopulations","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with specific and well-defined cellular developmental phenotype","pmids":["18195075"],"is_preprint":false},{"year":2011,"finding":"TOX is required to establish the full CD4+ T cell lineage gene program beyond its role in ThPOK induction; enforced ThPOK expression rescues some CD4 development in TOX-deficient mice but these cells remain defective in expression of Id2, Foxo1, and endogenous Thpok, demonstrating a ThPOK-independent role for TOX in CD4 lineage programming.","method":"TOX-deficient mouse, enforced ThPOK transgenic rescue, gene expression analysis of CD4 lineage markers","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with rescue experiment and multiple gene expression readouts","pmids":["22021617"],"is_preprint":false},{"year":2011,"finding":"TOX is a member of an evolutionarily conserved DNA-binding protein family expressed in immune-relevant cell subsets; it functions by modifying local chromatin structure and modulating formation of multi-protein complexes, with potential to regulate E protein activity during thymic development.","method":"Review synthesizing prior genetic and biochemical data on TOX family members","journal":"Current opinion in immunology","confidence":"Medium","confidence_rationale":"Tier 3 — mechanistic model synthesis without new direct experiments in this publication","pmids":["22209117"],"is_preprint":false},{"year":2014,"finding":"TOX is required for the in vivo differentiation of common lymphoid progenitors into ILC-lineage restricted cells; TOX deficiency causes early defects in progenitor survival/proliferation and later ILC differentiation defects, and TOX-deficient cells fail to upregulate ILC program genes including Notch targets.","method":"TOX-deficient mouse model, in vitro ILC differentiation assays, comparative transcriptome analysis of bone marrow progenitors","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO combined with in vitro modeling and transcriptome analysis, clear developmental phenotype","pmids":["25915732"],"is_preprint":false},{"year":2014,"finding":"TOX acts as a transcription factor during mammalian corticogenesis, regulated by calcineurin/NFAT signaling; DamID-seq identified TOX chromatin binding motif and downstream targets including Sox2, Tbr2, and Prox1; TOX promotes neural stem cell proliferation and neurite outgrowth of newborn neurons.","method":"DamID combined with deep sequencing (chromatin binding characterization), calcineurin/NFAT pathway analysis, in vivo brain manipulation of Tox expression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide chromatin binding mapping with functional in vivo validation and signaling pathway linkage","pmids":["25527292"],"is_preprint":false},{"year":2014,"finding":"Aberrant TOX overexpression in cutaneous T-cell lymphoma (CTCL) drives oncogenic growth; stable knockdown of TOX in CTCL cells promotes apoptosis, reduces cell cycle progression, and increases CDK inhibitors CDKN1B and CDKN1C; blocking CDKN1B and CDKN1C reverses the growth inhibition caused by TOX knockdown, placing TOX upstream of these CDK inhibitors.","method":"Stable shRNA knockdown in CTCL cell lines, in vitro viability/colony assays, in vivo xenograft tumor model, genetic epistasis with CDKN1B/C rescue","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (in vitro + in vivo) with genetic epistasis placing TOX upstream of CDKN1B/C","pmids":["25548321"],"is_preprint":false},{"year":2018,"finding":"TOX is induced in CD8+ CTLs during LCMV infection and is essential for their encephalitogenic properties in CNS autoimmunity; TOX represses activity of transcription factors Id2, TCF-1, and Notch, and reduces immune checkpoint sensitivity by restraining CD244 expression on CTLs, leading to increased CTL-mediated CNS damage.","method":"Mouse model of CNS inflammation with LCMV vs. Listeria infection, TOX expression analysis in CTLs, assessment of transcription factor targets and surface CD244 expression","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse model with mechanistic analysis of TOX targets and downstream effector molecules","pmids":["29768177"],"is_preprint":false},{"year":2019,"finding":"TOX is a central transcriptional and epigenetic regulator of CD8+ T cell exhaustion in mice; TOX is induced by calcineurin and NFAT2 and operates in a feed-forward loop becoming calcineurin-independent in exhausted T cells; in the absence of TOX, exhausted T cells fail to form, while effector and memory T cells develop normally.","method":"TOX knockout mouse, chronic LCMV infection model, ATAC-seq epigenetic profiling, calcineurin inhibitor treatment","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo genetic KO with epigenetic profiling (ATAC-seq) and upstream signaling pathway identification, replicated by two simultaneous Nature papers","pmids":["31207603"],"is_preprint":false},{"year":2019,"finding":"TOX is a crucial regulator of tumour-specific T cell differentiation; TOX expression is driven by chronic TCR stimulation and NFAT activation; ectopic TOX expression in effector T cells induces a transcriptional exhaustion program; Tox deletion abrogates upregulation of inhibitory receptors (PD-1, CD39, TIM-3, CD244, TIGIT) whose chromatin remains inaccessible, but TOX-deleted TST cells remain dysfunctional with impaired persistence in tumours.","method":"Ectopic TOX expression in effector T cells, Tox conditional knockout in tumor-infiltrating T cells, ATAC-seq chromatin accessibility profiling, tumor models","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — gain- and loss-of-function with epigenetic profiling, uncoupling of inhibitory receptor expression from effector dysfunction","pmids":["31207604"],"is_preprint":false},{"year":2019,"finding":"TOX is required for development and maintenance of exhausted T cell populations during chronic LCMV infection; removal of TOX's DNA-binding domain reduces PD-1 mRNA and protein levels and augments cytokine production, yielding more polyfunctional T cells; however, TOX-deficient exhausted T cells ultimately undergo massive decline in numbers, particularly among TCF-1+ self-renewing cells, indicating TOX is critical for their long-term maintenance and protection against activation-induced cell death.","method":"TOX DNA-binding domain deletion mouse, chronic LCMV infection, flow cytometric analysis of PD-1/cytokine production, quantification of TCF-1+ progenitor subset","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — domain-specific functional mutant combined with in vivo chronic infection model, replicated across multiple contemporaneous papers","pmids":["31207605"],"is_preprint":false},{"year":2019,"finding":"TOX and TOX2 cooperate with NR4A family nuclear receptors downstream of NFAT to impose the CD8+ T cell exhaustion transcriptional program; TOX and TOX2 are induced by calcium/calcineurin-NFAT signaling even without AP-1; TOX positively regulates NR4A expression and NR4A positively regulates TOX expression, forming a mutual amplification loop; combined deletion of TOX and TOX2 (DKO) in CAR T cells is more effective than single deletions in suppressing tumor growth.","method":"CAR T cell model, TOX/TOX2 double-knockout, NFAT and calcineurin inhibitor experiments, ATAC-seq chromatin accessibility, tumor suppression assays in vivo","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — genetic DKO with chromatin profiling and in vivo functional assays, identified TOX-NR4A mutual regulatory loop","pmids":["31152140"],"is_preprint":false},{"year":2019,"finding":"TOX promotes persistence of antiviral CD8+ T cells and is required for programming of progenitor-like CD8+ T cells during chronic viral infection; scRNA-seq showed a TOX-containing coexpression module with higher transcriptional activity and more active histone marks in progenitor-like cells compared to memory precursor cells.","method":"Single-cell RNA-seq, ATAC-seq/histone mark profiling, TOX-deficient mouse with chronic viral infection","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — multi-omic single-cell approach combined with in vivo KO phenotyping","pmids":["31209400"],"is_preprint":false},{"year":2019,"finding":"VEGF-A induces TOX expression in tumor-infiltrating T cells to drive the exhaustion-specific transcriptional program; combined PD-1 and VEGF-A blockade restores antitumor T cell functions in microsatellite stable colorectal cancer.","method":"In vitro VEGF-A treatment of T cells, ex vivo and in vivo mouse studies, combinatorial checkpoint/VEGF-A blockade experiments","journal":"Science immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple experimental systems establishing VEGF-A as upstream inducer of TOX expression","pmids":["31704735"],"is_preprint":false},{"year":2019,"finding":"TOX regulates follicular helper T (TFH) cell differentiation; TOX is highly upregulated in mouse and human TFH cells in a BCL6-dependent manner, and in turn promotes expression of molecules critical for TFH cell differentiation and function; the miR-23~27~24 cluster controls TFH cells partly by targeting TOX.","method":"miR-23~27~24 cluster T cell-specific knockout/overexpression, TOX expression analysis in TFH cells, BCL6 dependence assay","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — genetic miRNA loss/gain-of-function placing TOX downstream of BCL6 in TFH differentiation circuit","pmids":["31844658"],"is_preprint":false},{"year":2019,"finding":"TOX expression in cutaneous T-cell lymphoma is regulated by GATA3; GATA3 knockdown decreases TOX mRNA and protein expression in CTCL cells.","method":"siRNA knockdown of GATA3 in CTCL cell lines, qRT-PCR and western blot for TOX expression","journal":"Journal of the European Academy of Dermatology and Venereology","confidence":"Medium","confidence_rationale":"Tier 3 — single method (siRNA + mRNA/protein measurement) identifying GATA3 as upstream regulator of TOX","pmids":["27345620"],"is_preprint":false},{"year":2019,"finding":"In Sézary syndrome (CTCL), TOX is upregulated >7-fold and inversely correlates with RUNX3 expression; TOX siRNA knockdown rescues RUNX3 expression and reduces CTCL cell viability, placing TOX upstream of RUNX3 as a tumor suppressor pathway.","method":"siRNA-mediated TOX knockdown, qRT-PCR confirmation of TOX, RUNX3, GATA3 expression, pathway analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis by siRNA knockdown showing TOX negatively regulates RUNX3","pmids":["31139323"],"is_preprint":false},{"year":2021,"finding":"Continuous TOX expression is required for maintenance of the exhausted CD8+ T cell epigenetic fate; induced TOX ablation in already-committed exhausted T cells results in apoptotic-driven cell loss, reduced inhibitory receptor expression, decreased terminal differentiation, and greater fate flexibility toward effector-like states; epigenetic profiling revealed TOX maintains chromatin accessibility and transcriptional patterns in committed exhausted T cells.","method":"Inducible Cre-based TOX deletion in established exhausted T cells, ATAC-seq epigenetic profiling, gene expression profiling, flow cytometric phenotyping","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1-2 — inducible in vivo deletion with multi-omic profiling, demonstrating ongoing requirement for TOX beyond initial commitment","pmids":["40053604"],"is_preprint":false},{"year":2021,"finding":"Inflammatory cytokines (without TCR stimulation) are sufficient to upregulate TOX expression in both human and mouse CD8+ memory T cells; TOX is not necessary for cytokine-driven expression of PD-1, indicating these pathways are at least partially separable.","method":"Cytokine treatment of isolated human and mouse memory T cells, TOX knockout cells treated with cytokines, flow cytometric measurement of TOX and PD-1","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — clean experimental dissection using both human and mouse T cells with TOX KO controls","pmids":["34032638"],"is_preprint":false},{"year":2021,"finding":"TOX is required for TOX-dependent chromatin remodeling in self-reactive CD8+ T cells persisting in the CNS; TOX remodels >400 genomic regions including the Tcf7 locus; genetic ablation of TOX in CD8+ T cells results in shortened persistence of self-reactive T cells in the inflamed CNS during autoimmunity.","method":"TOX-deficient mouse model, ATAC-seq chromatin accessibility profiling of CNS-infiltrating CD8+ T cells, mouse model of CNS autoimmunity","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO with genome-wide ATAC-seq identifying specific genomic loci regulated by TOX","pmids":["33579927"],"is_preprint":false},{"year":2023,"finding":"STAT5a and TOX operate in a reciprocally antagonistic circuit in exhausted CD8+ T cells; constitutive Stat5a activity antagonizes TOX and rewires CD8+ T cells from exhaustion toward a durable effector/NK-like state with superior anti-tumor potential; temporal induction of Stat5 using an orthogonal IL-2:IL2Rβ pair fosters intermediate exhausted T cell accumulation and partially reprograms the epigenetic landscape of exhaustion.","method":"Constitutive Stat5a expression in T cells, orthogonal IL-2:IL2Rβ signaling system, ATAC-seq epigenetic profiling, tumor models, combined PD-L1 blockade","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1-2 — mechanistic circuit identified with multiple orthogonal genetic and pharmacological approaches plus epigenetic profiling","pmids":["38091951"],"is_preprint":false},{"year":2024,"finding":"LAG-3 sustains TOX expression and Tex cell durability; LAG-3 deficiency reduces TOX levels in exhausted CD8+ T cells; furthermore, LAG-3 governs a circuit generating a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b.","method":"LAG-3 knockout in chronic viral infection mouse model, PD-1 and/or LAG-3 blockade, flow cytometric analysis of TOX expression, CD94/NKG2 subset characterization, human parallel analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic KO with mechanistic dissection of non-redundant LAG-3 vs. PD-1 roles and identification of LAG-3→TOX axis","pmids":["39121847"],"is_preprint":false},{"year":2024,"finding":"CXCR4 orchestrates the TOX-programmed exhausted CD8+ T cell phenotype via the JAK2/STAT3 pathway; CXCR4 blockade attenuates the exhausted phenotype in vivo; single-cell RNA/TCR/ATAC-seq confirmed that Cxcr4-deficient CD8+ T cells epigenetically mitigate the transition from functional to exhausted phenotypes.","method":"CXCR4 blockade in vivo, Cxcr4 gene deficiency, single-cell RNA-seq/TCR-seq/ATAC-seq, JAK2/STAT3 pathway analysis","journal":"Cell genomics","confidence":"High","confidence_rationale":"Tier 2 — multi-omic single-cell approach with genetic KO and pharmacological blockade identifying CXCR4-JAK2-STAT3 as upstream regulator of TOX-programmed exhaustion","pmids":["39317187"],"is_preprint":false},{"year":2019,"finding":"In gastric cancer, TOX expression is suppressed relative to normal tissue; sanguinarine increases TOX expression while decreasing DNA-PKcs and KU70/80 expression, inhibiting tumorigenesis via the TOX/DNA-PKcs/KU70/80 signaling pathway.","method":"Network pharmacology target identification, MTT/colony formation assays, xenograft tumor model, qRT-PCR and western blot for TOX/DNA-PKcs/KU70/80","journal":"Pathology, research and practice","confidence":"Low","confidence_rationale":"Tier 3 — indirect pharmacological manipulation without direct TOX gain/loss-of-function; pathway placement is correlative","pmids":["31591052"],"is_preprint":false}],"current_model":"TOX is an HMG-box nuclear transcription factor that regulates chromatin accessibility and gene expression programs in immune cells: it is induced downstream of calcineurin/NFAT signaling (and also by inflammatory cytokines and VEGF-A) and operates in feed-forward loops with NR4A factors to epigenetically program and maintain CD8+ T cell exhaustion (requiring continuous expression to preserve the exhausted chromatin landscape), while also being essential for CD4 T cell and ILC lineage development in the thymus and for TFH cell differentiation in a BCL6-dependent manner; upstream regulators include NFAT, calcineurin, GATA3, BCL6, VEGF-A, and LAG-3, and antagonists include STAT5a, with TOX acting downstream to remodel hundreds of genomic loci including those encoding inhibitory receptors (PD-1, TIM-3, TIGIT) and stemness factors (TCF7/TCF-1), and in cancer cells TOX suppresses CDK inhibitors CDKN1B/C and negatively regulates RUNX3."},"narrative":{"teleology":[{"year":2002,"claim":"The discovery that TOX is an HMG-box protein selectively induced in immature thymocytes by TCR signaling and that its overexpression skews CD4/CD8 lineage ratios established TOX as a novel regulator of T cell development.","evidence":"Gene chip screen followed by transgenic mouse overexpression with thymocyte phenotyping","pmids":["11850626"],"confidence":"High","gaps":["Mechanism by which TOX alters lineage commitment was unknown","Loss-of-function data not yet available","Downstream gene targets unidentified"]},{"year":2004,"claim":"Demonstrating that TOX expression depends on calcineurin and that TOX suffices to induce CD8 gene demethylation and Runx3 upregulation linked TOX to an epigenetic mechanism of lineage specification downstream of TCR-calcineurin signaling.","evidence":"Calcineurin inhibitor treatment, TOX overexpression in thymocytes, CD8 locus methylation assay, Runx3 expression analysis in transgenic mice","pmids":["15078895"],"confidence":"High","gaps":["Whether TOX is necessary (not just sufficient) for CD4/CD8 specification was untested","Direct chromatin binding sites of TOX unknown"]},{"year":2008,"claim":"Genetic ablation of TOX revealed it is essential for CD4+ T cell, Treg, and NKT cell development — resolving the necessity question — while CD8+ T cells developed normally, establishing a lineage-selective requirement.","evidence":"TOX-knockout mouse with flow cytometric thymocyte phenotyping","pmids":["18195075"],"confidence":"High","gaps":["Whether TOX acts solely through ThPOK induction or has independent roles in CD4 programming was unresolved","Role in peripheral T cell function unknown"]},{"year":2011,"claim":"Epistasis experiments showed TOX has ThPOK-independent functions in installing the full CD4 lineage gene program, broadening its role beyond a single downstream target.","evidence":"Enforced ThPOK expression in TOX-KO mice with gene expression profiling of CD4 lineage markers (Id2, Foxo1, Thpok)","pmids":["22021617"],"confidence":"High","gaps":["Direct TOX-bound genomic loci in thymocytes remained uncharacterized","Whether TOX regulates chromatin structure directly or via cofactors was unclear"]},{"year":2014,"claim":"Extension of TOX's developmental role to innate lymphoid cell (ILC) lineage specification and demonstration of TOX function in corticogenesis via genome-wide DamID-seq binding analysis broadened the biological scope of TOX and identified its first direct genomic targets.","evidence":"TOX-KO mouse ILC differentiation assays with transcriptome profiling; DamID-seq chromatin binding in neural progenitors with in vivo brain manipulation","pmids":["25915732","25527292"],"confidence":"High","gaps":["Genome-wide binding sites in T cells specifically were not mapped","Whether neural and immune functions use shared or distinct target gene programs was unknown"]},{"year":2014,"claim":"Identification of TOX as an oncogenic driver in CTCL that suppresses CDK inhibitors CDKN1B and CDKN1C provided the first link between TOX and cancer cell-intrinsic proliferation control.","evidence":"Stable shRNA knockdown in CTCL cell lines, xenograft tumor model, genetic epistasis with CDKN1B/C rescue","pmids":["25548321"],"confidence":"High","gaps":["Whether TOX directly binds CDKN1B/C promoters or acts indirectly was unresolved","Upstream regulators of TOX in CTCL were not fully defined"]},{"year":2019,"claim":"Four landmark studies simultaneously established TOX as the central transcriptional and epigenetic regulator of CD8+ T cell exhaustion: TOX is induced by calcineurin/NFAT2, becomes calcineurin-independent in a feed-forward loop with NR4A factors, remodels chromatin at inhibitory receptor loci, and is essential for exhausted T cell formation but not effector/memory differentiation.","evidence":"TOX-KO and TOX DNA-binding domain mutant mice in chronic LCMV infection and tumor models; ectopic TOX expression in effector T cells; TOX/TOX2 DKO CAR T cells; ATAC-seq chromatin profiling across all studies","pmids":["31207603","31207604","31207605","31152140"],"confidence":"High","gaps":["Whether TOX is continuously required to maintain the exhausted state once established was unknown","Structural basis of TOX-chromatin interaction unresolved","Relative contributions of TOX vs. TOX2 in human exhaustion unclear"]},{"year":2019,"claim":"Identification of VEGF-A, BCL6, and GATA3 as additional upstream inducers of TOX expanded the regulatory inputs beyond calcineurin/NFAT, placing TOX at a convergence point of multiple signaling pathways in tumor microenvironment and lymphoid differentiation.","evidence":"VEGF-A treatment of T cells with in vivo validation; BCL6-dependent TFH cell TOX upregulation with miRNA epistasis; GATA3 siRNA knockdown in CTCL cells","pmids":["31704735","31844658","27345620"],"confidence":"Medium","gaps":["Whether VEGF-A acts directly on TOX promoter or through intermediate factors was not established","GATA3→TOX link shown only in CTCL cell lines with single method"]},{"year":2021,"claim":"Inducible deletion of TOX in already-committed exhausted T cells demonstrated that continuous TOX expression is required to maintain the exhausted epigenetic landscape; TOX ablation caused apoptosis, reduced inhibitory receptors, and increased fate flexibility, establishing TOX as both an initiator and sustainer of the exhausted state.","evidence":"Inducible Cre-mediated TOX deletion in established exhausted T cells during chronic infection, ATAC-seq and gene expression profiling","pmids":["40053604"],"confidence":"High","gaps":["Mechanism by which TOX loss triggers apoptosis not defined","Whether re-expression of TOX can restore the exhausted program after ablation was untested"]},{"year":2021,"claim":"Demonstrating that inflammatory cytokines alone (without TCR stimulation) induce TOX but that cytokine-driven PD-1 expression is TOX-independent partially decoupled the TOX-PD-1 axis and revealed pathway separability.","evidence":"Cytokine stimulation of human and mouse memory T cells with and without TOX knockout, flow cytometric analysis","pmids":["34032638"],"confidence":"Medium","gaps":["Which cytokine-responsive transcription factors drive TOX-independent PD-1 was not identified","Relevance to chronic infection vs. tumor settings unclear"]},{"year":2023,"claim":"Identification of STAT5a as a direct antagonist of TOX that can reprogram exhausted T cells toward a durable effector/NK-like state defined a reciprocal regulatory circuit governing the exhaustion-effector fate decision.","evidence":"Constitutive Stat5a expression in T cells, orthogonal IL-2/IL-2Rβ system, ATAC-seq, tumor models with PD-L1 blockade","pmids":["38091951"],"confidence":"High","gaps":["Whether STAT5a directly represses TOX transcription or acts post-transcriptionally was not resolved","Long-term durability of STAT5a-reprogrammed cells in patients unknown"]},{"year":2024,"claim":"Placing LAG-3 upstream of TOX as a sustainer of TOX expression in exhausted T cells, and CXCR4/JAK2/STAT3 as an additional upstream axis, revealed new signaling inputs that maintain the exhaustion program and represent therapeutic targets.","evidence":"LAG-3-KO chronic viral infection model with TOX expression quantification; CXCR4 blockade and KO with single-cell multiomics (RNA/TCR/ATAC-seq)","pmids":["39121847","39317187"],"confidence":"High","gaps":["Whether LAG-3 regulates TOX transcription or protein stability is undefined","Whether CXCR4-STAT3 and LAG-3 pathways converge on the same TOX regulatory elements is unknown"]},{"year":null,"claim":"The structural basis of TOX HMG-box interaction with chromatin, the identity of cofactors that mediate TOX-dependent chromatin remodeling in T cells, and whether pharmacological targeting of TOX can modulate exhaustion in human immunotherapy remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of TOX HMG-box bound to nucleosomal DNA","Chromatin remodeling cofactors recruited by TOX in T cells not identified","No small-molecule modulators of TOX function reported"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,6,11]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[9,10,12,18]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,6,9]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[6,9,10,20]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,5,9,10,11,12,13]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[1,9,10,18,20]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,10,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,3,5,6]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,17]}],"complexes":[],"partners":["NFAT2","NR4A1","TOX2","BCL6","STAT5A","RUNX3","LAG3","THPOK"],"other_free_text":[]},"mechanistic_narrative":"TOX is an HMG-box transcription factor that functions as a master regulator of immune cell fate by remodeling chromatin accessibility at hundreds of genomic loci to establish and maintain lineage-specific gene programs. In the thymus, TOX is induced downstream of calcineurin signaling and is essential for CD4+ T cell, regulatory T cell, NKT cell, and innate lymphoid cell development, acting partly through ThPOK-independent mechanisms to install the full CD4 lineage transcriptional program [PMID:18195075, PMID:22021617, PMID:25915732]. In the context of chronic antigen stimulation, TOX is induced by NFAT2 and sustained by signals from LAG-3 and CXCR4/JAK2/STAT3; it cooperates with TOX2 and NR4A factors in a mutual amplification loop to epigenetically program CD8+ T cell exhaustion, opening chromatin at inhibitory receptor loci (PD-1, TIM-3, TIGIT) and the Tcf7 locus while being continuously required to maintain the exhausted epigenetic state and protect against activation-induced cell death [PMID:31207603, PMID:31207604, PMID:31152140, PMID:40053604, PMID:39121847]. TOX also promotes follicular helper T cell differentiation downstream of BCL6 and drives oncogenic proliferation in cutaneous T-cell lymphoma by suppressing the CDK inhibitors CDKN1B and CDKN1C [PMID:31844658, PMID:25548321]."},"prefetch_data":{"uniprot":{"accession":"O94900","full_name":"Thymocyte selection-associated high mobility group box protein TOX","aliases":["Thymus high mobility group box protein TOX"],"length_aa":526,"mass_kda":57.5,"function":"Transcriptional regulator with a major role in neural stem cell commitment and corticogenesis as well as in lymphoid cell development and lymphoid tissue organogenesis (By similarity). Binds to GC-rich DNA sequences in the proximity of transcription start sites and may alter chromatin structure, modifying access of transcription factors to DNA. During cortical development, controls the neural stem cell pool by inhibiting the switch from proliferative to differentiating progenitors. Beyond progenitor cells, promotes neurite outgrowth in newborn neurons migrating to reach the cortical plate. May activate or repress critical genes for neural stem cell fate such as SOX2, EOMES and ROBO2 (By similarity). Plays an essential role in the development of lymphoid tissue-inducer (LTi) cells, a subset necessary for the formation of secondary lymphoid organs: peripheral lymph nodes and Peyer's patches. Acts as a developmental checkpoint and regulates thymocyte positive selection toward T cell lineage commitment. Required for the development of various T cell subsets, including CD4-positive helper T cells, CD8-positive cytotoxic T cells, regulatory T cells and CD1D-dependent natural killer T (NKT) cells. Required for the differentiation of common lymphoid progenitors (CMP) to innate lymphoid cells (ILC) (By similarity). May regulate the NOTCH-mediated gene program, promoting differentiation of the ILC lineage. Required at the progenitor phase of NK cell development in the bone marrow to specify NK cell lineage commitment (By similarity) (PubMed:21126536). Upon chronic antigen stimulation, diverts T cell development by promoting the generation of exhaustive T cells, while suppressing effector and memory T cell programming. May regulate the expression of genes encoding inhibitory receptors such as PDCD1 and induce the exhaustion program, to prevent the overstimulation of T cells and activation-induced cell death (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O94900/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TOX","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TOX","total_profiled":1310},"omim":[{"mim_id":"614032","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 4; TOX4","url":"https://www.omim.org/entry/614032"},{"mim_id":"611416","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 3; TOX3","url":"https://www.omim.org/entry/611416"},{"mim_id":"611163","title":"TOX HIGH MOBILITY GROUP BOX FAMILY MEMBER 2; TOX2","url":"https://www.omim.org/entry/611163"},{"mim_id":"611046","title":"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2","url":"https://www.omim.org/entry/611046"},{"mim_id":"606863","title":"THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX; TOX","url":"https://www.omim.org/entry/606863"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":48.8}],"url":"https://www.proteinatlas.org/search/TOX"},"hgnc":{"alias_symbol":["KIAA0808","TOX1"],"prev_symbol":[]},"alphafold":{"accession":"O94900","domains":[{"cath_id":"1.10.30.10","chopping":"259-334","consensus_level":"medium","plddt":93.1324,"start":259,"end":334}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94900","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94900-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94900-F1-predicted_aligned_error_v6.png","plddt_mean":54.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TOX","jax_strain_url":"https://www.jax.org/strain/search?query=TOX"},"sequence":{"accession":"O94900","fasta_url":"https://rest.uniprot.org/uniprotkb/O94900.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94900/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94900"}},"corpus_meta":[{"pmid":"31207603","id":"PMC_31207603","title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207603","citation_count":1241,"is_preprint":false},{"pmid":"31207604","id":"PMC_31207604","title":"TOX is a critical regulator of tumour-specific T cell differentiation.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207604","citation_count":878,"is_preprint":false},{"pmid":"31207605","id":"PMC_31207605","title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31207605","citation_count":713,"is_preprint":false},{"pmid":"31152140","id":"PMC_31152140","title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8+ T cell exhaustion.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31152140","citation_count":613,"is_preprint":false},{"pmid":"31209400","id":"PMC_31209400","title":"Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31209400","citation_count":433,"is_preprint":false},{"pmid":"2195332","id":"PMC_2195332","title":"The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1990","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/2195332","citation_count":382,"is_preprint":false},{"pmid":"6173747","id":"PMC_6173747","title":"Sister-chromatid exchanges: a report of the GENE-TOX program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6173747","citation_count":380,"is_preprint":false},{"pmid":"7035931","id":"PMC_7035931","title":"Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7035931","citation_count":285,"is_preprint":false},{"pmid":"6835246","id":"PMC_6835246","title":"An evaluation of the mouse sperm morphology test and other sperm tests in nonhuman mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6835246","citation_count":283,"is_preprint":false},{"pmid":"7035930","id":"PMC_7035930","title":"Mammalian in vivo and in vitro cytogenetic assays: a report of the U.S. EPA's gene-tox program.","date":"1981","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7035930","citation_count":242,"is_preprint":false},{"pmid":"3528831","id":"PMC_3528831","title":"The Salmonella typhimurium/mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1986","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3528831","citation_count":241,"is_preprint":false},{"pmid":"2116013","id":"PMC_2116013","title":"Molecular cloning and DNA sequence analysis of a diphtheria tox iron-dependent regulatory element (dtxR) from Corynebacterium diphtheriae.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2116013","citation_count":208,"is_preprint":false},{"pmid":"7177154","id":"PMC_7177154","title":"Chromosome aberration assays in Allium. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7177154","citation_count":203,"is_preprint":false},{"pmid":"31704735","id":"PMC_31704735","title":"VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.","date":"2019","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31704735","citation_count":189,"is_preprint":false},{"pmid":"18195075","id":"PMC_18195075","title":"Development of all CD4 T lineages requires nuclear factor TOX.","date":"2008","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18195075","citation_count":185,"is_preprint":false},{"pmid":"32620560","id":"PMC_32620560","title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells.","date":"2020","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32620560","citation_count":181,"is_preprint":false},{"pmid":"7687323","id":"PMC_7687323","title":"Sister-chromatid exchange: second report of the Gene-Tox Program.","date":"1993","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7687323","citation_count":168,"is_preprint":false},{"pmid":"7809094","id":"PMC_7809094","title":"Tagged mutations at the Tox1 locus of Cochliobolus heterostrophus by restriction enzyme-mediated integration.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7809094","citation_count":160,"is_preprint":false},{"pmid":"25915732","id":"PMC_25915732","title":"The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25915732","citation_count":153,"is_preprint":false},{"pmid":"11850626","id":"PMC_11850626","title":"TOX: an HMG box protein implicated in the regulation of thymocyte selection.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11850626","citation_count":151,"is_preprint":false},{"pmid":"10657208","id":"PMC_10657208","title":"Biology and molecular epidemiology of diphtheria toxin and the tox gene.","date":"2000","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10657208","citation_count":142,"is_preprint":false},{"pmid":"6413857","id":"PMC_6413857","title":"The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6413857","citation_count":133,"is_preprint":false},{"pmid":"9697776","id":"PMC_9697776","title":"Structure of the metal-ion-activated diphtheria toxin repressor/tox operator complex.","date":"1998","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9697776","citation_count":132,"is_preprint":false},{"pmid":"6835247","id":"PMC_6835247","title":"An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6835247","citation_count":131,"is_preprint":false},{"pmid":"6358881","id":"PMC_6358881","title":"Unscheduled DNA synthesis tests. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1983","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6358881","citation_count":108,"is_preprint":false},{"pmid":"30063238","id":"PMC_30063238","title":"A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX.","date":"2018","source":"Lab on a chip","url":"https://pubmed.ncbi.nlm.nih.gov/30063238","citation_count":106,"is_preprint":false},{"pmid":"6374444","id":"PMC_6374444","title":"Testing of chemicals for genetic activity with Saccharomyces cerevisiae: a report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6374444","citation_count":103,"is_preprint":false},{"pmid":"38091951","id":"PMC_38091951","title":"Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure.","date":"2023","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/38091951","citation_count":91,"is_preprint":false},{"pmid":"22209117","id":"PMC_22209117","title":"The many roles of TOX in the immune system.","date":"2011","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22209117","citation_count":91,"is_preprint":false},{"pmid":"9431944","id":"PMC_9431944","title":"Multicenter evaluation of the Clostridium difficile TOX A/B TEST.","date":"1998","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9431944","citation_count":87,"is_preprint":false},{"pmid":"15683867","id":"PMC_15683867","title":"Tox-Prot, the toxin protein annotation program of the Swiss-Prot protein knowledgebase.","date":"2004","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/15683867","citation_count":81,"is_preprint":false},{"pmid":"15472364","id":"PMC_15472364","title":"Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.","date":"2004","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15472364","citation_count":78,"is_preprint":false},{"pmid":"3889623","id":"PMC_3889623","title":"Current status of bioassays in genetic toxicology--the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1985","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3889623","citation_count":76,"is_preprint":false},{"pmid":"39121847","id":"PMC_39121847","title":"LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/39121847","citation_count":76,"is_preprint":false},{"pmid":"3110596","id":"PMC_3110596","title":"Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain.","date":"1987","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3110596","citation_count":75,"is_preprint":false},{"pmid":"1400485","id":"PMC_1400485","title":"Binding of the metalloregulatory protein DtxR to the diphtheria tox operator requires a divalent heavy metal ion and protects the palindromic sequence from DNase I digestion.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1400485","citation_count":69,"is_preprint":false},{"pmid":"4204202","id":"PMC_4204202","title":"Synthesis of diphtheria tox-gene products in Escherichia coli extracts.","date":"1974","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/4204202","citation_count":65,"is_preprint":false},{"pmid":"33097558","id":"PMC_33097558","title":"TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection.","date":"2020","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/33097558","citation_count":64,"is_preprint":false},{"pmid":"29768177","id":"PMC_29768177","title":"Expression of the DNA-Binding Factor TOX Promotes the Encephalitogenic Potential of Microbe-Induced Autoreactive CD8+ T Cells.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29768177","citation_count":63,"is_preprint":false},{"pmid":"25548321","id":"PMC_25548321","title":"Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25548321","citation_count":63,"is_preprint":false},{"pmid":"15078895","id":"PMC_15078895","title":"TOX provides a link between calcineurin activation and CD8 lineage commitment.","date":"2004","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15078895","citation_count":62,"is_preprint":false},{"pmid":"33249194","id":"PMC_33249194","title":"TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/33249194","citation_count":62,"is_preprint":false},{"pmid":"30932078","id":"PMC_30932078","title":"3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30932078","citation_count":61,"is_preprint":false},{"pmid":"1631071","id":"PMC_1631071","title":"Specific binding of the diphtheria tox regulatory element DtxR to the tox operator requires divalent heavy metal ions and a 9-base-pair interrupted palindromic sequence.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1631071","citation_count":61,"is_preprint":false},{"pmid":"22021617","id":"PMC_22021617","title":"TOX is required for development of the CD4 T cell lineage gene program.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22021617","citation_count":59,"is_preprint":false},{"pmid":"7240352","id":"PMC_7240352","title":"The GENE-TOX program: genetic activity evaluation.","date":"1981","source":"Journal of chemical information and computer sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7240352","citation_count":57,"is_preprint":false},{"pmid":"29398302","id":"PMC_29398302","title":"Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies.","date":"2018","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/29398302","citation_count":56,"is_preprint":false},{"pmid":"32535080","id":"PMC_32535080","title":"Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32535080","citation_count":45,"is_preprint":false},{"pmid":"24842659","id":"PMC_24842659","title":"ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.","date":"2014","source":"Pharmaceutical research","url":"https://pubmed.ncbi.nlm.nih.gov/24842659","citation_count":45,"is_preprint":false},{"pmid":"820871","id":"PMC_820871","title":"Characterization and genetic mapping of nontoxinogenic (tox) mutants of corynebacteriophage beta.","date":"1976","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/820871","citation_count":45,"is_preprint":false},{"pmid":"7050697","id":"PMC_7050697","title":"An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7050697","citation_count":44,"is_preprint":false},{"pmid":"25527292","id":"PMC_25527292","title":"Tox: a multifunctional transcription factor and novel regulator of mammalian corticogenesis.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/25527292","citation_count":42,"is_preprint":false},{"pmid":"24925458","id":"PMC_24925458","title":"Emergence and molecular characterisation of non-toxigenic tox gene-bearing Corynebacterium diphtheriae biovar mitis in the United Kingdom, 2003-2012.","date":"2014","source":"Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/24925458","citation_count":42,"is_preprint":false},{"pmid":"34873490","id":"PMC_34873490","title":"Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8+ cytolytic T cells.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34873490","citation_count":37,"is_preprint":false},{"pmid":"820874","id":"PMC_820874","title":"Orientation of the tox gene in the prophage of corynebacteriophage beta.","date":"1976","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/820874","citation_count":37,"is_preprint":false},{"pmid":"3285185","id":"PMC_3285185","title":"The genetic toxicology of Gene-Tox non-carcinogens.","date":"1988","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3285185","citation_count":35,"is_preprint":false},{"pmid":"34032638","id":"PMC_34032638","title":"Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34032638","citation_count":35,"is_preprint":false},{"pmid":"30087301","id":"PMC_30087301","title":"TRPs in Tox: Involvement of Transient Receptor Potential-Channels in Chemical-Induced Organ Toxicity-A Structured Review.","date":"2018","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/30087301","citation_count":34,"is_preprint":false},{"pmid":"17266641","id":"PMC_17266641","title":"Biological fingerprinting analysis of traditional Chinese medicines with targeting ADME/Tox property for screening of bioactive compounds by chromatographic and MS methods.","date":"2007","source":"Mini reviews in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17266641","citation_count":33,"is_preprint":false},{"pmid":"3292898","id":"PMC_3292898","title":"A review and analysis of the Chinese hamster ovary/hypoxanthine guanine phosphoribosyl transferase assay to determine the mutagenicity of chemical agents. A report of phase III of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1988","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/3292898","citation_count":32,"is_preprint":false},{"pmid":"6231482","id":"PMC_6231482","title":"Mutation tests in Neurospora crassa. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1984","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/6231482","citation_count":31,"is_preprint":false},{"pmid":"2411714","id":"PMC_2411714","title":"Characterization of the diphtheria tox transcript in Corynebacterium diphtheriae and Escherichia coli.","date":"1985","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2411714","citation_count":31,"is_preprint":false},{"pmid":"33296081","id":"PMC_33296081","title":"Antigen-driven PD-1+ TOX+ BHLHE40+ and PD-1+ TOX+ EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ.","date":"2021","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33296081","citation_count":30,"is_preprint":false},{"pmid":"16054403","id":"PMC_16054403","title":"Systems-ADME/Tox: resources and network approaches.","date":"2005","source":"Journal of pharmacological and toxicological methods","url":"https://pubmed.ncbi.nlm.nih.gov/16054403","citation_count":30,"is_preprint":false},{"pmid":"31844658","id":"PMC_31844658","title":"MiR-23~27~24-mediated control of humoral immunity reveals a TOX-driven regulatory circuit in follicular helper T cell differentiation.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31844658","citation_count":30,"is_preprint":false},{"pmid":"34211801","id":"PMC_34211801","title":"Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML.","date":"2021","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/34211801","citation_count":30,"is_preprint":false},{"pmid":"35111387","id":"PMC_35111387","title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.","date":"2022","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/35111387","citation_count":29,"is_preprint":false},{"pmid":"27345620","id":"PMC_27345620","title":"TOX expression and role in CTCL.","date":"2016","source":"Journal of the European Academy of Dermatology and Venereology : JEADV","url":"https://pubmed.ncbi.nlm.nih.gov/27345620","citation_count":29,"is_preprint":false},{"pmid":"33579927","id":"PMC_33579927","title":"Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33579927","citation_count":29,"is_preprint":false},{"pmid":"26885442","id":"PMC_26885442","title":"TOX gene: a novel target for human cancer gene therapy.","date":"2015","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26885442","citation_count":27,"is_preprint":false},{"pmid":"39317187","id":"PMC_39317187","title":"CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway.","date":"2024","source":"Cell genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39317187","citation_count":27,"is_preprint":false},{"pmid":"7050696","id":"PMC_7050696","title":"DNA repair assays as tests for environmental mutagens. A report of the U.S. EPA Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7050696","citation_count":27,"is_preprint":false},{"pmid":"31139323","id":"PMC_31139323","title":"Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/31139323","citation_count":26,"is_preprint":false},{"pmid":"31949884","id":"PMC_31949884","title":"LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31949884","citation_count":26,"is_preprint":false},{"pmid":"36969216","id":"PMC_36969216","title":"TOX regulates T lymphocytes differentiation and its function in tumor.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36969216","citation_count":24,"is_preprint":false},{"pmid":"31817628","id":"PMC_31817628","title":"Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro.","date":"2019","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/31817628","citation_count":24,"is_preprint":false},{"pmid":"31267892","id":"PMC_31267892","title":"Corynebacterium diphtheriae: Diphtheria Toxin, the tox Operon, and Its Regulation by Fe2+ Activation of apo-DtxR.","date":"2019","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/31267892","citation_count":23,"is_preprint":false},{"pmid":"40053604","id":"PMC_40053604","title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate.","date":"2025","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40053604","citation_count":23,"is_preprint":false},{"pmid":"32757053","id":"PMC_32757053","title":"Expression pattern, regulation, and clinical significance of TOX in breast cancer.","date":"2020","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/32757053","citation_count":23,"is_preprint":false},{"pmid":"9404504","id":"PMC_9404504","title":"Analysis of heterogeneity of Corynebacterium diphtheriae toxin gene, tox, and its regulatory element, dtxR, by direct sequencing.","date":"1997","source":"Research in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9404504","citation_count":23,"is_preprint":false},{"pmid":"36865465","id":"PMC_36865465","title":"QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/36865465","citation_count":23,"is_preprint":false},{"pmid":"36743017","id":"PMC_36743017","title":"Cyclohexane-1,3-dione Derivatives as Future Therapeutic Agents for NSCLC: QSAR Modeling, In Silico ADME-Tox Properties, and Structure-Based Drug Designing Approach.","date":"2023","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/36743017","citation_count":23,"is_preprint":false},{"pmid":"34854367","id":"PMC_34854367","title":"Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME/Tox prediction, 2D/3D QSAR and molecular dynamics simulation.","date":"2021","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/34854367","citation_count":22,"is_preprint":false},{"pmid":"28327672","id":"PMC_28327672","title":"TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28327672","citation_count":20,"is_preprint":false},{"pmid":"34220814","id":"PMC_34220814","title":"NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34220814","citation_count":20,"is_preprint":false},{"pmid":"35246241","id":"PMC_35246241","title":"Increased TOX expression associates with exhausted T cells in patients with multiple myeloma.","date":"2022","source":"Experimental hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35246241","citation_count":19,"is_preprint":false},{"pmid":"25482955","id":"PMC_25482955","title":"Polymorphisms in TOX and NCOA2 genes and their associations with reproductive traits in cattle.","date":"2015","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/25482955","citation_count":17,"is_preprint":false},{"pmid":"19465657","id":"PMC_19465657","title":"Biochemical evidence for ToxR and ToxJ binding to the tox operons of Burkholderia glumae and mutational analysis of ToxR.","date":"2009","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/19465657","citation_count":17,"is_preprint":false},{"pmid":"33608984","id":"PMC_33608984","title":"Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.","date":"2021","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33608984","citation_count":16,"is_preprint":false},{"pmid":"25777533","id":"PMC_25777533","title":"Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.","date":"2015","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25777533","citation_count":16,"is_preprint":false},{"pmid":"7177157","id":"PMC_7177157","title":"Specific-locus mutation assays in Zea mays. A report of the U.S. Environmental Protection Agency Gene-Tox Program.","date":"1982","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/7177157","citation_count":16,"is_preprint":false},{"pmid":"30609117","id":"PMC_30609117","title":"Chemical structure modifications and nano-technology applications for improving ADME-Tox properties, a review.","date":"2019","source":"Archiv der Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/30609117","citation_count":16,"is_preprint":false},{"pmid":"32106280","id":"PMC_32106280","title":"High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32106280","citation_count":15,"is_preprint":false},{"pmid":"19710910","id":"PMC_19710910","title":"Spodoptera frugiperda X-tox protein, an immune related defensin rosary, has lost the function of ancestral defensins.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19710910","citation_count":15,"is_preprint":false},{"pmid":"26139146","id":"PMC_26139146","title":"TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26139146","citation_count":14,"is_preprint":false},{"pmid":"31885353","id":"PMC_31885353","title":"Potential Therapeutic Approaches to Alzheimer's Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools.","date":"2020","source":"Current neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31885353","citation_count":13,"is_preprint":false},{"pmid":"36841617","id":"PMC_36841617","title":"Molecular modeling study of pyrrolidine derivatives as novel myeloid cell leukemia-1 inhibitors through combined 3D-QSAR, molecular docking, ADME/Tox and MD simulation techniques.","date":"2023","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/36841617","citation_count":13,"is_preprint":false},{"pmid":"36758706","id":"PMC_36758706","title":"Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.","date":"2023","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36758706","citation_count":12,"is_preprint":false},{"pmid":"31591052","id":"PMC_31591052","title":"Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/31591052","citation_count":12,"is_preprint":false},{"pmid":"35485425","id":"PMC_35485425","title":"The TOX subfamily: all-round players in the immune system.","date":"2022","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35485425","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45388,"output_tokens":6027,"usd":0.113284},"stage2":{"model":"claude-opus-4-6","input_tokens":9618,"output_tokens":3404,"usd":0.199785},"total_usd":0.313069,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"TOX is an HMG-box DNA-binding protein whose expression is upregulated by both pre-TCR and TCR activation of immature thymocytes but not by TCR activation of mature naïve T cells; transgenic overexpression of TOX in mice expands CD8+ and reduces CD4+ single positive thymocyte subpopulations by perturbing lineage commitment through reduced sensitivity to TCR-mediated signaling.\",\n      \"method\": \"Gene chip isolation of Tox, transgenic mouse overexpression, thymocyte phenotyping\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original discovery paper with transgenic mouse model and defined cellular phenotype, replicated by subsequent studies\",\n      \"pmids\": [\"11850626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TOX expression in double-positive thymocytes is calcineurin-dependent; TOX is sufficient to induce CD8 gene demethylation, initiate positive selection to the CD8 lineage independently of MHC-TCR interactions, and upregulate Runx3, implicating CD4 silencing. A strong TCR signal can override this TOX-mediated cell fate.\",\n      \"method\": \"Calcineurin inhibitor treatment, TOX overexpression in thymocytes, CD8 gene methylation assay, Runx3 expression analysis, transgenic mouse studies\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including epigenetic (methylation) assay, genetic overexpression, and signaling pathway epistasis\",\n      \"pmids\": [\"15078895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TOX is required for CD4 T cell lineage development; loss of TOX causes a severe block at the CD4loCD8lo transitional stage of positive selection, resulting in failure of CD4+ T cells, regulatory T cells, and NKT cells to develop, while functional CD8+ T cells are generated normally.\",\n      \"method\": \"TOX-deficient (knockout) mouse model, flow cytometric phenotyping of thymocyte subpopulations\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with specific and well-defined cellular developmental phenotype\",\n      \"pmids\": [\"18195075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TOX is required to establish the full CD4+ T cell lineage gene program beyond its role in ThPOK induction; enforced ThPOK expression rescues some CD4 development in TOX-deficient mice but these cells remain defective in expression of Id2, Foxo1, and endogenous Thpok, demonstrating a ThPOK-independent role for TOX in CD4 lineage programming.\",\n      \"method\": \"TOX-deficient mouse, enforced ThPOK transgenic rescue, gene expression analysis of CD4 lineage markers\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with rescue experiment and multiple gene expression readouts\",\n      \"pmids\": [\"22021617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TOX is a member of an evolutionarily conserved DNA-binding protein family expressed in immune-relevant cell subsets; it functions by modifying local chromatin structure and modulating formation of multi-protein complexes, with potential to regulate E protein activity during thymic development.\",\n      \"method\": \"Review synthesizing prior genetic and biochemical data on TOX family members\",\n      \"journal\": \"Current opinion in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — mechanistic model synthesis without new direct experiments in this publication\",\n      \"pmids\": [\"22209117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TOX is required for the in vivo differentiation of common lymphoid progenitors into ILC-lineage restricted cells; TOX deficiency causes early defects in progenitor survival/proliferation and later ILC differentiation defects, and TOX-deficient cells fail to upregulate ILC program genes including Notch targets.\",\n      \"method\": \"TOX-deficient mouse model, in vitro ILC differentiation assays, comparative transcriptome analysis of bone marrow progenitors\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO combined with in vitro modeling and transcriptome analysis, clear developmental phenotype\",\n      \"pmids\": [\"25915732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TOX acts as a transcription factor during mammalian corticogenesis, regulated by calcineurin/NFAT signaling; DamID-seq identified TOX chromatin binding motif and downstream targets including Sox2, Tbr2, and Prox1; TOX promotes neural stem cell proliferation and neurite outgrowth of newborn neurons.\",\n      \"method\": \"DamID combined with deep sequencing (chromatin binding characterization), calcineurin/NFAT pathway analysis, in vivo brain manipulation of Tox expression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide chromatin binding mapping with functional in vivo validation and signaling pathway linkage\",\n      \"pmids\": [\"25527292\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Aberrant TOX overexpression in cutaneous T-cell lymphoma (CTCL) drives oncogenic growth; stable knockdown of TOX in CTCL cells promotes apoptosis, reduces cell cycle progression, and increases CDK inhibitors CDKN1B and CDKN1C; blocking CDKN1B and CDKN1C reverses the growth inhibition caused by TOX knockdown, placing TOX upstream of these CDK inhibitors.\",\n      \"method\": \"Stable shRNA knockdown in CTCL cell lines, in vitro viability/colony assays, in vivo xenograft tumor model, genetic epistasis with CDKN1B/C rescue\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vitro + in vivo) with genetic epistasis placing TOX upstream of CDKN1B/C\",\n      \"pmids\": [\"25548321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TOX is induced in CD8+ CTLs during LCMV infection and is essential for their encephalitogenic properties in CNS autoimmunity; TOX represses activity of transcription factors Id2, TCF-1, and Notch, and reduces immune checkpoint sensitivity by restraining CD244 expression on CTLs, leading to increased CTL-mediated CNS damage.\",\n      \"method\": \"Mouse model of CNS inflammation with LCMV vs. Listeria infection, TOX expression analysis in CTLs, assessment of transcription factor targets and surface CD244 expression\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model with mechanistic analysis of TOX targets and downstream effector molecules\",\n      \"pmids\": [\"29768177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is a central transcriptional and epigenetic regulator of CD8+ T cell exhaustion in mice; TOX is induced by calcineurin and NFAT2 and operates in a feed-forward loop becoming calcineurin-independent in exhausted T cells; in the absence of TOX, exhausted T cells fail to form, while effector and memory T cells develop normally.\",\n      \"method\": \"TOX knockout mouse, chronic LCMV infection model, ATAC-seq epigenetic profiling, calcineurin inhibitor treatment\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo genetic KO with epigenetic profiling (ATAC-seq) and upstream signaling pathway identification, replicated by two simultaneous Nature papers\",\n      \"pmids\": [\"31207603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is a crucial regulator of tumour-specific T cell differentiation; TOX expression is driven by chronic TCR stimulation and NFAT activation; ectopic TOX expression in effector T cells induces a transcriptional exhaustion program; Tox deletion abrogates upregulation of inhibitory receptors (PD-1, CD39, TIM-3, CD244, TIGIT) whose chromatin remains inaccessible, but TOX-deleted TST cells remain dysfunctional with impaired persistence in tumours.\",\n      \"method\": \"Ectopic TOX expression in effector T cells, Tox conditional knockout in tumor-infiltrating T cells, ATAC-seq chromatin accessibility profiling, tumor models\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — gain- and loss-of-function with epigenetic profiling, uncoupling of inhibitory receptor expression from effector dysfunction\",\n      \"pmids\": [\"31207604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX is required for development and maintenance of exhausted T cell populations during chronic LCMV infection; removal of TOX's DNA-binding domain reduces PD-1 mRNA and protein levels and augments cytokine production, yielding more polyfunctional T cells; however, TOX-deficient exhausted T cells ultimately undergo massive decline in numbers, particularly among TCF-1+ self-renewing cells, indicating TOX is critical for their long-term maintenance and protection against activation-induced cell death.\",\n      \"method\": \"TOX DNA-binding domain deletion mouse, chronic LCMV infection, flow cytometric analysis of PD-1/cytokine production, quantification of TCF-1+ progenitor subset\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific functional mutant combined with in vivo chronic infection model, replicated across multiple contemporaneous papers\",\n      \"pmids\": [\"31207605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX and TOX2 cooperate with NR4A family nuclear receptors downstream of NFAT to impose the CD8+ T cell exhaustion transcriptional program; TOX and TOX2 are induced by calcium/calcineurin-NFAT signaling even without AP-1; TOX positively regulates NR4A expression and NR4A positively regulates TOX expression, forming a mutual amplification loop; combined deletion of TOX and TOX2 (DKO) in CAR T cells is more effective than single deletions in suppressing tumor growth.\",\n      \"method\": \"CAR T cell model, TOX/TOX2 double-knockout, NFAT and calcineurin inhibitor experiments, ATAC-seq chromatin accessibility, tumor suppression assays in vivo\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic DKO with chromatin profiling and in vivo functional assays, identified TOX-NR4A mutual regulatory loop\",\n      \"pmids\": [\"31152140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX promotes persistence of antiviral CD8+ T cells and is required for programming of progenitor-like CD8+ T cells during chronic viral infection; scRNA-seq showed a TOX-containing coexpression module with higher transcriptional activity and more active histone marks in progenitor-like cells compared to memory precursor cells.\",\n      \"method\": \"Single-cell RNA-seq, ATAC-seq/histone mark profiling, TOX-deficient mouse with chronic viral infection\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic single-cell approach combined with in vivo KO phenotyping\",\n      \"pmids\": [\"31209400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"VEGF-A induces TOX expression in tumor-infiltrating T cells to drive the exhaustion-specific transcriptional program; combined PD-1 and VEGF-A blockade restores antitumor T cell functions in microsatellite stable colorectal cancer.\",\n      \"method\": \"In vitro VEGF-A treatment of T cells, ex vivo and in vivo mouse studies, combinatorial checkpoint/VEGF-A blockade experiments\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple experimental systems establishing VEGF-A as upstream inducer of TOX expression\",\n      \"pmids\": [\"31704735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX regulates follicular helper T (TFH) cell differentiation; TOX is highly upregulated in mouse and human TFH cells in a BCL6-dependent manner, and in turn promotes expression of molecules critical for TFH cell differentiation and function; the miR-23~27~24 cluster controls TFH cells partly by targeting TOX.\",\n      \"method\": \"miR-23~27~24 cluster T cell-specific knockout/overexpression, TOX expression analysis in TFH cells, BCL6 dependence assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic miRNA loss/gain-of-function placing TOX downstream of BCL6 in TFH differentiation circuit\",\n      \"pmids\": [\"31844658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TOX expression in cutaneous T-cell lymphoma is regulated by GATA3; GATA3 knockdown decreases TOX mRNA and protein expression in CTCL cells.\",\n      \"method\": \"siRNA knockdown of GATA3 in CTCL cell lines, qRT-PCR and western blot for TOX expression\",\n      \"journal\": \"Journal of the European Academy of Dermatology and Venereology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single method (siRNA + mRNA/protein measurement) identifying GATA3 as upstream regulator of TOX\",\n      \"pmids\": [\"27345620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Sézary syndrome (CTCL), TOX is upregulated >7-fold and inversely correlates with RUNX3 expression; TOX siRNA knockdown rescues RUNX3 expression and reduces CTCL cell viability, placing TOX upstream of RUNX3 as a tumor suppressor pathway.\",\n      \"method\": \"siRNA-mediated TOX knockdown, qRT-PCR confirmation of TOX, RUNX3, GATA3 expression, pathway analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis by siRNA knockdown showing TOX negatively regulates RUNX3\",\n      \"pmids\": [\"31139323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Continuous TOX expression is required for maintenance of the exhausted CD8+ T cell epigenetic fate; induced TOX ablation in already-committed exhausted T cells results in apoptotic-driven cell loss, reduced inhibitory receptor expression, decreased terminal differentiation, and greater fate flexibility toward effector-like states; epigenetic profiling revealed TOX maintains chromatin accessibility and transcriptional patterns in committed exhausted T cells.\",\n      \"method\": \"Inducible Cre-based TOX deletion in established exhausted T cells, ATAC-seq epigenetic profiling, gene expression profiling, flow cytometric phenotyping\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — inducible in vivo deletion with multi-omic profiling, demonstrating ongoing requirement for TOX beyond initial commitment\",\n      \"pmids\": [\"40053604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Inflammatory cytokines (without TCR stimulation) are sufficient to upregulate TOX expression in both human and mouse CD8+ memory T cells; TOX is not necessary for cytokine-driven expression of PD-1, indicating these pathways are at least partially separable.\",\n      \"method\": \"Cytokine treatment of isolated human and mouse memory T cells, TOX knockout cells treated with cytokines, flow cytometric measurement of TOX and PD-1\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean experimental dissection using both human and mouse T cells with TOX KO controls\",\n      \"pmids\": [\"34032638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TOX is required for TOX-dependent chromatin remodeling in self-reactive CD8+ T cells persisting in the CNS; TOX remodels >400 genomic regions including the Tcf7 locus; genetic ablation of TOX in CD8+ T cells results in shortened persistence of self-reactive T cells in the inflamed CNS during autoimmunity.\",\n      \"method\": \"TOX-deficient mouse model, ATAC-seq chromatin accessibility profiling of CNS-infiltrating CD8+ T cells, mouse model of CNS autoimmunity\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with genome-wide ATAC-seq identifying specific genomic loci regulated by TOX\",\n      \"pmids\": [\"33579927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"STAT5a and TOX operate in a reciprocally antagonistic circuit in exhausted CD8+ T cells; constitutive Stat5a activity antagonizes TOX and rewires CD8+ T cells from exhaustion toward a durable effector/NK-like state with superior anti-tumor potential; temporal induction of Stat5 using an orthogonal IL-2:IL2Rβ pair fosters intermediate exhausted T cell accumulation and partially reprograms the epigenetic landscape of exhaustion.\",\n      \"method\": \"Constitutive Stat5a expression in T cells, orthogonal IL-2:IL2Rβ signaling system, ATAC-seq epigenetic profiling, tumor models, combined PD-L1 blockade\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mechanistic circuit identified with multiple orthogonal genetic and pharmacological approaches plus epigenetic profiling\",\n      \"pmids\": [\"38091951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LAG-3 sustains TOX expression and Tex cell durability; LAG-3 deficiency reduces TOX levels in exhausted CD8+ T cells; furthermore, LAG-3 governs a circuit generating a CD94/NKG2+ subset of exhausted T cells with enhanced cytotoxicity mediated by recognition of the stress ligand Qa-1b.\",\n      \"method\": \"LAG-3 knockout in chronic viral infection mouse model, PD-1 and/or LAG-3 blockade, flow cytometric analysis of TOX expression, CD94/NKG2 subset characterization, human parallel analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with mechanistic dissection of non-redundant LAG-3 vs. PD-1 roles and identification of LAG-3→TOX axis\",\n      \"pmids\": [\"39121847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CXCR4 orchestrates the TOX-programmed exhausted CD8+ T cell phenotype via the JAK2/STAT3 pathway; CXCR4 blockade attenuates the exhausted phenotype in vivo; single-cell RNA/TCR/ATAC-seq confirmed that Cxcr4-deficient CD8+ T cells epigenetically mitigate the transition from functional to exhausted phenotypes.\",\n      \"method\": \"CXCR4 blockade in vivo, Cxcr4 gene deficiency, single-cell RNA-seq/TCR-seq/ATAC-seq, JAK2/STAT3 pathway analysis\",\n      \"journal\": \"Cell genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic single-cell approach with genetic KO and pharmacological blockade identifying CXCR4-JAK2-STAT3 as upstream regulator of TOX-programmed exhaustion\",\n      \"pmids\": [\"39317187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In gastric cancer, TOX expression is suppressed relative to normal tissue; sanguinarine increases TOX expression while decreasing DNA-PKcs and KU70/80 expression, inhibiting tumorigenesis via the TOX/DNA-PKcs/KU70/80 signaling pathway.\",\n      \"method\": \"Network pharmacology target identification, MTT/colony formation assays, xenograft tumor model, qRT-PCR and western blot for TOX/DNA-PKcs/KU70/80\",\n      \"journal\": \"Pathology, research and practice\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — indirect pharmacological manipulation without direct TOX gain/loss-of-function; pathway placement is correlative\",\n      \"pmids\": [\"31591052\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TOX is an HMG-box nuclear transcription factor that regulates chromatin accessibility and gene expression programs in immune cells: it is induced downstream of calcineurin/NFAT signaling (and also by inflammatory cytokines and VEGF-A) and operates in feed-forward loops with NR4A factors to epigenetically program and maintain CD8+ T cell exhaustion (requiring continuous expression to preserve the exhausted chromatin landscape), while also being essential for CD4 T cell and ILC lineage development in the thymus and for TFH cell differentiation in a BCL6-dependent manner; upstream regulators include NFAT, calcineurin, GATA3, BCL6, VEGF-A, and LAG-3, and antagonists include STAT5a, with TOX acting downstream to remodel hundreds of genomic loci including those encoding inhibitory receptors (PD-1, TIM-3, TIGIT) and stemness factors (TCF7/TCF-1), and in cancer cells TOX suppresses CDK inhibitors CDKN1B/C and negatively regulates RUNX3.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TOX is an HMG-box transcription factor that functions as a master regulator of immune cell fate by remodeling chromatin accessibility at hundreds of genomic loci to establish and maintain lineage-specific gene programs. In the thymus, TOX is induced downstream of calcineurin signaling and is essential for CD4+ T cell, regulatory T cell, NKT cell, and innate lymphoid cell development, acting partly through ThPOK-independent mechanisms to install the full CD4 lineage transcriptional program [PMID:18195075, PMID:22021617, PMID:25915732]. In the context of chronic antigen stimulation, TOX is induced by NFAT2 and sustained by signals from LAG-3 and CXCR4/JAK2/STAT3; it cooperates with TOX2 and NR4A factors in a mutual amplification loop to epigenetically program CD8+ T cell exhaustion, opening chromatin at inhibitory receptor loci (PD-1, TIM-3, TIGIT) and the Tcf7 locus while being continuously required to maintain the exhausted epigenetic state and protect against activation-induced cell death [PMID:31207603, PMID:31207604, PMID:31152140, PMID:40053604, PMID:39121847]. TOX also promotes follicular helper T cell differentiation downstream of BCL6 and drives oncogenic proliferation in cutaneous T-cell lymphoma by suppressing the CDK inhibitors CDKN1B and CDKN1C [PMID:31844658, PMID:25548321].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"The discovery that TOX is an HMG-box protein selectively induced in immature thymocytes by TCR signaling and that its overexpression skews CD4/CD8 lineage ratios established TOX as a novel regulator of T cell development.\",\n      \"evidence\": \"Gene chip screen followed by transgenic mouse overexpression with thymocyte phenotyping\",\n      \"pmids\": [\"11850626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TOX alters lineage commitment was unknown\", \"Loss-of-function data not yet available\", \"Downstream gene targets unidentified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that TOX expression depends on calcineurin and that TOX suffices to induce CD8 gene demethylation and Runx3 upregulation linked TOX to an epigenetic mechanism of lineage specification downstream of TCR-calcineurin signaling.\",\n      \"evidence\": \"Calcineurin inhibitor treatment, TOX overexpression in thymocytes, CD8 locus methylation assay, Runx3 expression analysis in transgenic mice\",\n      \"pmids\": [\"15078895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX is necessary (not just sufficient) for CD4/CD8 specification was untested\", \"Direct chromatin binding sites of TOX unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic ablation of TOX revealed it is essential for CD4+ T cell, Treg, and NKT cell development — resolving the necessity question — while CD8+ T cells developed normally, establishing a lineage-selective requirement.\",\n      \"evidence\": \"TOX-knockout mouse with flow cytometric thymocyte phenotyping\",\n      \"pmids\": [\"18195075\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX acts solely through ThPOK induction or has independent roles in CD4 programming was unresolved\", \"Role in peripheral T cell function unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Epistasis experiments showed TOX has ThPOK-independent functions in installing the full CD4 lineage gene program, broadening its role beyond a single downstream target.\",\n      \"evidence\": \"Enforced ThPOK expression in TOX-KO mice with gene expression profiling of CD4 lineage markers (Id2, Foxo1, Thpok)\",\n      \"pmids\": [\"22021617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct TOX-bound genomic loci in thymocytes remained uncharacterized\", \"Whether TOX regulates chromatin structure directly or via cofactors was unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extension of TOX's developmental role to innate lymphoid cell (ILC) lineage specification and demonstration of TOX function in corticogenesis via genome-wide DamID-seq binding analysis broadened the biological scope of TOX and identified its first direct genomic targets.\",\n      \"evidence\": \"TOX-KO mouse ILC differentiation assays with transcriptome profiling; DamID-seq chromatin binding in neural progenitors with in vivo brain manipulation\",\n      \"pmids\": [\"25915732\", \"25527292\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding sites in T cells specifically were not mapped\", \"Whether neural and immune functions use shared or distinct target gene programs was unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of TOX as an oncogenic driver in CTCL that suppresses CDK inhibitors CDKN1B and CDKN1C provided the first link between TOX and cancer cell-intrinsic proliferation control.\",\n      \"evidence\": \"Stable shRNA knockdown in CTCL cell lines, xenograft tumor model, genetic epistasis with CDKN1B/C rescue\",\n      \"pmids\": [\"25548321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX directly binds CDKN1B/C promoters or acts indirectly was unresolved\", \"Upstream regulators of TOX in CTCL were not fully defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Four landmark studies simultaneously established TOX as the central transcriptional and epigenetic regulator of CD8+ T cell exhaustion: TOX is induced by calcineurin/NFAT2, becomes calcineurin-independent in a feed-forward loop with NR4A factors, remodels chromatin at inhibitory receptor loci, and is essential for exhausted T cell formation but not effector/memory differentiation.\",\n      \"evidence\": \"TOX-KO and TOX DNA-binding domain mutant mice in chronic LCMV infection and tumor models; ectopic TOX expression in effector T cells; TOX/TOX2 DKO CAR T cells; ATAC-seq chromatin profiling across all studies\",\n      \"pmids\": [\"31207603\", \"31207604\", \"31207605\", \"31152140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TOX is continuously required to maintain the exhausted state once established was unknown\", \"Structural basis of TOX-chromatin interaction unresolved\", \"Relative contributions of TOX vs. TOX2 in human exhaustion unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of VEGF-A, BCL6, and GATA3 as additional upstream inducers of TOX expanded the regulatory inputs beyond calcineurin/NFAT, placing TOX at a convergence point of multiple signaling pathways in tumor microenvironment and lymphoid differentiation.\",\n      \"evidence\": \"VEGF-A treatment of T cells with in vivo validation; BCL6-dependent TFH cell TOX upregulation with miRNA epistasis; GATA3 siRNA knockdown in CTCL cells\",\n      \"pmids\": [\"31704735\", \"31844658\", \"27345620\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether VEGF-A acts directly on TOX promoter or through intermediate factors was not established\", \"GATA3→TOX link shown only in CTCL cell lines with single method\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Inducible deletion of TOX in already-committed exhausted T cells demonstrated that continuous TOX expression is required to maintain the exhausted epigenetic landscape; TOX ablation caused apoptosis, reduced inhibitory receptors, and increased fate flexibility, establishing TOX as both an initiator and sustainer of the exhausted state.\",\n      \"evidence\": \"Inducible Cre-mediated TOX deletion in established exhausted T cells during chronic infection, ATAC-seq and gene expression profiling\",\n      \"pmids\": [\"40053604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TOX loss triggers apoptosis not defined\", \"Whether re-expression of TOX can restore the exhausted program after ablation was untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrating that inflammatory cytokines alone (without TCR stimulation) induce TOX but that cytokine-driven PD-1 expression is TOX-independent partially decoupled the TOX-PD-1 axis and revealed pathway separability.\",\n      \"evidence\": \"Cytokine stimulation of human and mouse memory T cells with and without TOX knockout, flow cytometric analysis\",\n      \"pmids\": [\"34032638\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which cytokine-responsive transcription factors drive TOX-independent PD-1 was not identified\", \"Relevance to chronic infection vs. tumor settings unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of STAT5a as a direct antagonist of TOX that can reprogram exhausted T cells toward a durable effector/NK-like state defined a reciprocal regulatory circuit governing the exhaustion-effector fate decision.\",\n      \"evidence\": \"Constitutive Stat5a expression in T cells, orthogonal IL-2/IL-2Rβ system, ATAC-seq, tumor models with PD-L1 blockade\",\n      \"pmids\": [\"38091951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether STAT5a directly represses TOX transcription or acts post-transcriptionally was not resolved\", \"Long-term durability of STAT5a-reprogrammed cells in patients unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placing LAG-3 upstream of TOX as a sustainer of TOX expression in exhausted T cells, and CXCR4/JAK2/STAT3 as an additional upstream axis, revealed new signaling inputs that maintain the exhaustion program and represent therapeutic targets.\",\n      \"evidence\": \"LAG-3-KO chronic viral infection model with TOX expression quantification; CXCR4 blockade and KO with single-cell multiomics (RNA/TCR/ATAC-seq)\",\n      \"pmids\": [\"39121847\", \"39317187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether LAG-3 regulates TOX transcription or protein stability is undefined\", \"Whether CXCR4-STAT3 and LAG-3 pathways converge on the same TOX regulatory elements is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis of TOX HMG-box interaction with chromatin, the identity of cofactors that mediate TOX-dependent chromatin remodeling in T cells, and whether pharmacological targeting of TOX can modulate exhaustion in human immunotherapy remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of TOX HMG-box bound to nucleosomal DNA\", \"Chromatin remodeling cofactors recruited by TOX in T cells not identified\", \"No small-molecule modulators of TOX function reported\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 11]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9, 10, 12, 18]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 6, 9]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [6, 9, 10, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 5, 9, 10, 11, 12, 13]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [1, 9, 10, 18, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 10, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NFAT2\",\n      \"NR4A1\",\n      \"TOX2\",\n      \"BCL6\",\n      \"STAT5A\",\n      \"RUNX3\",\n      \"LAG3\",\n      \"ThPOK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}